KRAS and cancer: To determine whether deltarasin-induced autophagy plays a pro-survival or pro-death effect in KRAS-dependent cancer, pre-treatment with autophagy inhibitor 3-MA enhanced deltarasin-mediated cytotoxicity, suggesting that deltarasin-induced autophagy may play a protective role in KRAS-dependent lung cancer cells.